These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7769845)

  • 1. Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis.
    Gokhale DA; Evans DG; Crowther D; Woll P; Watson CJ; Dearden SP; Fergusson WD; Stevens RF; Taylor GM
    Leukemia; 1995 May; 9(5):826-33. PubMed ID: 7769845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.
    Taylor GM; Gokhale DA; Crowther D; Woll P; Harris M; Alexander F; Jarrett R; Cartwright RA
    Leukemia; 1996 May; 10(5):854-9. PubMed ID: 8656683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility?
    Siebert R; Fosså A; Kaiser W; Welt A; Ferencik S; Seeber S; Nowrousian MR
    Leuk Lymphoma; 1997 Jun; 26(1-2):121-5. PubMed ID: 9250796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.
    Taylor GM; Gokhale DA; Crowther D; Woll PJ; Harris M; Ryder D; Ayres M; Radford JA
    Br J Cancer; 1999 Jul; 80(9):1405-11. PubMed ID: 10424743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoautosomal linkage of Hodgkin disease.
    Horwitz M; Wiernik PH
    Am J Hum Genet; 1999 Nov; 65(5):1413-22. PubMed ID: 10521308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
    Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated: response to Dorak, Mills, Poynton and Burnett.
    Taylor GM; Gokhale DA
    Leukemia; 1996 Nov; 10(11):1850-1. PubMed ID: 8892697
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis.
    Shears DJ; Vassal HJ; Goodman FR; Palmer RW; Reardon W; Superti-Furga A; Scambler PJ; Winter RM
    Nat Genet; 1998 May; 19(1):70-3. PubMed ID: 9590293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands.
    Benito-Sanz S; del Blanco DG; Aza-Carmona M; Magano LF; Lapunzina P; Argente J; Campos-Barros A; Heath KE
    Hum Mutat; 2006 Oct; 27(10):1062. PubMed ID: 16941489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class II DPB1*26012: a novel DPB1 sequence and its presumed origin.
    Meyer CG; Spauke D; Schnittger L
    Tissue Antigens; 1994 May; 43(5):324-6. PubMed ID: 7940502
    [No Abstract]   [Full Text] [Related]  

  • 14. Deletion of Xpter encompassing the SHOX gene and PAR1 region in familial patients with Leri-Weill Dyschondrosteosis syndrome.
    Mutesa L; Vanbellinghen JF; Hellin AC; Segers K; Jamar M; Pierquin G; Bours V
    Genet Couns; 2009; 20(1):9-17. PubMed ID: 19400538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA class II polymorphism using polymerase chain reaction.
    Erlich H; Bugawan T; Begovich A; Scharf S
    Arch Pathol Lab Med; 1993 May; 117(5):482-5. PubMed ID: 8489336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).
    Belin V; Cusin V; Viot G; Girlich D; Toutain A; Moncla A; Vekemans M; Le Merrer M; Munnich A; Cormier-Daire V
    Nat Genet; 1998 May; 19(1):67-9. PubMed ID: 9590292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudodominant inheritance of Langer mesomelic dysplasia caused by a SHOX homeobox missense mutation.
    Shears DJ; Guillen-Navarro E; Sempere-Miralles M; Domingo-Jimenez R; Scambler PJ; Winter RM
    Am J Med Genet; 2002 Jun; 110(2):153-7. PubMed ID: 12116253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomenclature for factors of the HLA system, update July 1996. The WHO Nomenclature Committee for factors of the HLA system.
    Marsh SG
    Hum Immunol; 1997 Jan; 52(1):72. PubMed ID: 9021411
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.